Myriad Genetics MYGN

Health care sectorNasdaq

Company

Exchange: Nasdaq
Sector: Health care
Industry: In Vitro & In Vivo Diagnostic Substances
Headquarters: Salt Lake City, Utah
Fiscal year end: 12/31
Next earnings: 10/09, estimated

Korean holdings rank: Outside the top 50; Korea Securities Depository · released 09/22
Congress trades: No record; Last 90 days · 0 buys · 0 sales
Insider net buying: No record; Last 90 days · 0 buys · 0 sales
Next earnings: 10/09; Estimated from the last four quarters

26-week trading